MondaySep 26, 2022 11:34 am

TinyGemsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Issues Letter to Stockholders

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, today released a letter to stockholders from its Chief Executive Officer Dr. James Woody. In the letter, Dr. Woody discussed the company’s continued status to remain on track with clinical development plans. “Currently, we have an active clinical development program that includes phase 2a and phase 2b proof-of-concept data, which we believe demonstrates that anti-TNF therapy can prevent the progression of Dupuytren’s disease in its early stages, as well as plans for two additional phase 2 studies, one in frozen shoulder, which has recently commenced, and the other in post-operative cognitive…

Continue Reading

MondaySep 26, 2022 11:23 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Dates for Strikingly Different Fall Tour

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released the kickoff dates for its Strikingly Different tour; the fall tour features the Mullen FIVE EV Crossover. The tour begins on Oct. 27–28, 2022, at the Rose Bowl in Pasadena followed by a stop at the Las Vegas Motor Speedway on Nov. 10–11. In addition, the tour will make stops in both Dallas and Houston in November, with December locations slated in Memphis, Miami, Atlanta and Charlotte. The second leg of the tour will begin in spring 2023 with the tour heading to the East Coast as well…

Continue Reading

MondaySep 26, 2022 10:35 am

TinyGemsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Unveils In-House Product Design Studio

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, announced that it now has in-house design capabilities. Called Ideanomics Design, the new approach will strengthen the company’s position as a leading commercial EV and allow the company to have a powerful impact on the future of commercial EV solutions by creating high-performance electric mobility and charging solutions. According to the announcement, the new service will also embed a more cost-effective, efficient and standardized design process across the company. Ideanomics operates three verticals: Mobility, Energy and Capital. Each one is charged with being accountable for managing…

Continue Reading

MondaySep 26, 2022 10:21 am

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Expands Global Footprint to Add 3 International Markets

Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. The company today announced that it has completed its first exports of Colombian grown high-CBD dried cannabis flower to Switzerland and the Czech Republic as well as CBD isolate to the United States. “As our global distribution network continues to evolve, adding these three industry-leading countries to our footprint is a major milestone for Flora,” said Luis Merchan, chairman and CEO of Flora Growth. “Our cultivation operation in Colombia, which provides high-quality, high-margin flower and derivatives, has experienced increasing demand. These exports are…

Continue Reading

FridaySep 23, 2022 2:40 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces 2022 Financial Results, Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the fiscal year ended June 30, 2022. “In the final quarter of our fiscal 2022, as well as throughout the previous fiscal year, we have made important advancements in our pharmaceutical drug development programs, including expanding our phase 2 clinical trial for the treatment of symptoms related to epidermolysis bullosa to include adolescents, and initiating a research collaboration agreement to further screen cannabinoid analogs for potential therapeutic uses. As announced on Sept. 8, 2022, we have…

Continue Reading

FridaySep 23, 2022 12:08 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Virtual Investor Innovations in Oncology Event

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that its Chief Executive Officer John Climaco will present at the following event at 1:00 p.m. ET on Wednesday, Sept. 28, 2022: Virtual Investor Innovations in Oncology – Ongoing Pivotal Global Study for Treatment of Glioblastoma Multiforme (“GBM”). As part of the virtual event, Climaco will discuss the company’s ongoing potentially pivotal global study evaluating its efficacy and safety in the treatment of GBM. Interested parties should visit https://ibn.fm/ktCnW…

Continue Reading

FridaySep 23, 2022 10:39 am

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Secures Contract with Global Commercial Real Estate Broker

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that one of the largest commercial real estate services companies in the world has reached an agreement to engage Knightscope’s K5 Autonomous Security Robot (“ASR”) patrols for a prominent Chicago skyscraper. According to Knightscope, this is the company’s first contract in Chicago and the state of Illinois. The announcement reads, “The real estate, renting and leasing industry employs over 2 million people and is one of the largest sectors in the U.S. economy, accounting for over 10% of the country’s GDP. One…

Continue Reading

WednesdaySep 21, 2022 3:05 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Collaborates to Bridge Concept-to-Deployment Gap in Autonomous Driving Technology

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has announced its collaboration with NVIDIA to add Cepton lidar models into NVIDIA DRIVE Sim(TM). According to the update, DRIVE Sim is an end-to-end simulation platform that enables large-scale, physically based multi-sensor simulation to support the development and validation of autonomous driving. “Lidar is essential to autonomous mobility, but deploying lidar at scale entails extensive testing and validation, sometimes in scenarios difficult to access in real life,” said Dr. Jun Pei, Cepton’s co-founder and CEO. “Simulation plays a significant role in bridging the gap between concept and…

Continue Reading

WednesdaySep 21, 2022 1:07 pm

TinyGemsBreaks — Mullen Automotive Inc.’s (NASDAQ: MULN) Bollinger Motors Teams Up with Wabash to Develop New Body on Electric Chassis

Mullen Automotive (NASDAQ: MULN), through its recent majority acquisition, Bollinger Motors Inc., is partnering with Wabash, a leading truck body and trailer manufacturer. The partnership will focus on developing a stronger, lighter, refrigerated truck body on an electric chassis. The plan is to seamlessly integrate Bollinger’s Class 4 electric chassis cab with Wabash’s lightweight composite technology, EcoNex(TM), which will be used in truck bodies and trailers. According to the announcement, the exclusive EcoNex technology’s composite material is lighter and more durable and thermally efficient than other commercial products. With that in mind, the new offering will feature weight savings because…

Continue Reading

WednesdaySep 21, 2022 12:10 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation in Upcoming Scientific and Investor Conferences

Cybin (NYSE American: CYBN) (NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(TM). The company today announced its participation in upcoming conferences taking place in September and October 2022. The company’s CEO Doug Drysdale participated in a panel discussion titled “Trials to Treatments” at the Interdisciplinary Conference on Psychedelic Research, Psychedelic Science, Ethics & Business Event in Haarlem, Amsterdam. The announcement includes further details on additional conferences and the participation schedule for Drysdale and additional members of Cybin’s management team in panel discussions and presentations. The additional events include the Interdisciplinary Conference on Psychedelic Research, Sept. 22-24,…

Continue Reading

Contact us: (512) 354-7000